CLINICAL STUDY ON MICROWAVE DEEP HYPERTHERMIA COMBINED WITH HEPATIC ARTERY EMBOLISATION AND PORTAL VEIN PERFUSION IN THE TREATMENT OF ADVANCED LIVER CANCER

Zongzhi Liang*, #, Daoke Yang**, Weigong Cheng***, Guangming Cui****

*Department of Tumor Thermotherapy Combination, Provincial Hospital of Henan Province, Zhengzhou, PR China - **Department of Radiation, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, PR China - ***Department of Oncology, Zhoukou Yongxing Hospital, Zhoukou, PR China - ****Department of Urinary Surgery, Zhoukou Yongxing Hospital, Zhoukou, PR China

Objective: We sought to analyse the clinical effects of microwave deep hyperthermia combined with hepatic artery embolisation and portal vein perfusion in the treatment of advanced liver cancer. 

Methods: Sixty-six patients with advanced liver cancer who were treated in our hospital from June 2004 to June 2015 were selected and divided into the treatment group (33 cases) and the control group (33 cases) according to statistical and scientific grouping methods. In our hospital, patients in the treatment group were treated with hyperthermia combined with hepatic artery embolisation and portal vein drug perfusion, while those in the control group were treated with simple hepatic artery embolisation combined with portal vein drug perfusion. 

Results: The treatment effect, AFP level, KPS score change, ascites control, overall survival rate, and adverse reactions were significantly different between the treatment group and the control group, with the former largely showing better results than the latter in a statistically significant manner (P<0.05).